Atlas Trials

A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Transplantation

Clinical trial NCT02112045 · TERMINATED

Trial details

NCT number
NCT02112045
Sponsor
Washington University School of Medicine
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2015-01-20
Primary completion
2017-12-13
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.